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Vitamin D insufficiency is a worldwide epidemic
affecting billions of individuals, including pregnant
women and children. Despite its high incidence, the
impact of active vitamin D3 (1,25(OH)D3) on embry-
onic development beyond osteo-regulation remains
largely undefined. Here, we demonstrate that
1,25(OH)D3 availability modulates zebrafish hemato-
poietic stem and progenitor cell (HSPC) production.
Loss of Cyp27b1-mediated biosynthesis or vitamin
D receptor (VDR) function by gene knockdown re-
sulted in significantly reduced runx1 expression
and Flk1+cMyb+ HSPC numbers. Selective modula-
tion in vivo and in vitro in zebrafish indicated that
vitamin D3 acts directly on HSPCs, independent of
calcium regulation, to increase proliferation. Notably,
ex vivo treatment of human HSPCs with 1,25(OH)D3
also enhanced hematopoietic colony numbers, illus-
trating conservation across species. Finally, gene
expression and epistasis analysis indicated that
CXCL8 (IL-8) was a functional target of vitamin D3-
mediated HSPC regulation. Together, these findings
highlight the relevance of developmental 1,25(OH)D3
availability for definitive hematopoiesis and suggest
potential therapeutic utility in HSPC expansion.INTRODUCTION
Characterizing the impact of environmental modifiers on he-
matopoietic stem and progenitor cell (HSPC) formation and
maintenance is of significant therapeutic interest because these
extrinsic factors may influence both the onset and outcome of
hematological disease. Active vitamin D (1,25(OH)D3), a fat-
soluble hormone required for many physiological functions, is
derived via sunlight and diet in humans. As such, factors
including geographical location, lifestyle, and nutritional regimen458 Cell Reports 17, 458–468, October 4, 2016 ª 2016 The Author(s)
This is an open access article under the CC BY-NC-ND license (http://can impact the level of vitamin D sufficiency. Recent studies indi-
cate that vitamin D insufficiency is now a global epidemic,
affecting over 1 billion people (Naeem, 2010). Among pregnant
women, the worldwide incidence of 1,25(OH)D3 deficiency is
estimated to be between 6% and 96% depending on geograph-
ical location and availability of supplementation (Weinert and Sil-
veiro, 2015), with a particularly high occurrence in industrialized
regions (40%–50%) (Bodnar et al., 2007). Severe 1,25(OH)D3
deficiency because of biosynthetic or signaling pathway muta-
tions results in insufficient calcium (Ca2+) absorption and
abnormal bone mineralization, leading to rickets in children
and osteomalacia in adults. Interestingly, case studies of chil-
dren with severe vitamin D deficiency present a variety of hema-
tological disorders (Holick, 2006; Yetgin and Ozsoylu, 1982);
however, the impact of vitamin D status on embryonic hemato-
poietic stem cell (HSC) production has not been elucidated.
De novo vitamin D synthesis begins with transformation of
7-dehydrocholesterol in the skin by UV radiation to the non-
active vitamin D precursor cholecalciferol (D3). D3 is then modi-
fied by cytochrome P450 enzyme 2R1 (CYP2R1), primarily in the
liver, to generate 25-hydroxy vitamin D (25(OH)D3, calcidiol), the
circulating form of vitamin D. In the kidney, 25(OH)D3 is further
hydroxylated by CYP27B1 to generate the active metabolite
1,25-dihydroxy vitamin D (1,25(OH)D3, calcitriol). 1,25(OH)D3
acts as a ligand for the vitamin D receptor (VDR), a member of
the nuclear hormone receptor family (Mizwicki and Norman,
2009). Upon ligand binding, VDR forms a heterodimer with the
retinoic acid X receptor (RXR), resulting in nuclear localization
and transcriptional regulation of genes with vitamin D response
elements (VDREs) (Plum and DeLuca, 2010). Genome-wide
chromatin immunoprecipitation sequencing (ChIP-seq) studies
identified more than 200 VDR-regulated genes (Ramagopalan
et al., 2010). 1,25(OH)D3/VDR binding can also elicit non-
genomic responses, including extracellular Ca2+ uptake (Nor-
man, 2006).
In humans, mutations in genes of the vitamin D biosynthetic
pathway are the most common cause of vitamin D-dependent
rickets (VDDR), whereas VDR mutations result in hereditary
vitamin D-resistant rickets (HVDR) (Holick, 2006). VDDR is
treated with vitamin D supplementation, whereas HVDR is.
creativecommons.org/licenses/by-nc-nd/4.0/).
partially ameliorated with supplemental Ca2+. Children with
vitamin D deficiency-associated rickets are clinically docu-
mented to exhibit a variety of hematopoietic defects, including
anemia, extramedullary hematopoiesis, thrombocytopenia,
myelofibrosis, and myelodysplasia. Some features improve
with Ca2+ supplementation, suggestive of bone marrow (BM)
niche dysregulation (Yetgin and Ozsoylu, 1982). Indeed, VDR
loss in the mouse leads to extramedullary hematopoiesis
because of abnormal bone mineralization (Jeanson and Scad-
den, 2010). In contrast, expression analyses indicate that VDR
is one of 33 genes highly enriched in mouse HSCs (Riddell
et al., 2014). VDR levels vary as immune cells mature, withmono-
cytes/macrophages showing downregulation (Hewison et al.,
2003) and T cells upregulation, respectively (Bruce and Can-
torna, 2011). Subsets of T cells also express Cyp27b1, implying
that local 1,25(OH)D3 synthesis may be important for T cell func-
tion (Ooi et al., 2014). Further, Cyp27b1-null mice show reduc-
tions in CD4 and CD8 T cells (Panda et al., 2001). Similar to
mice, VDR is broadly expressed in human hematopoietic cells
(Kizaki et al., 1991). Children with von Jaksch-Luzet syndrome,
a severe vitamin D deficiency, are characterized by anemia
with accumulation of erythroblasts and myeloblasts resembling
chronic myeloid leukemia (Holick, 2006; Kassam et al., 1983).
Despite multi-lineage abnormalities and frequent childhood
onset, minimal investigation has been made into the impact of
vitamin D status on developmental HSPC production.
Unlike adult HSPC homeostasis, which is strongly regulated
by interactions with the BM microenvironment, embryonic he-
matopoiesis is initiated de novo in specialized vascular niches
with transient hematopoietic potential (Carroll and North,
2014). Here we present a role for active vitamin D3 in embryonic
HSPC production: 1,25(OH)D3 levels directly impact HSPC
numbers in vivo and in vitro via VDR-mediated regulation of
pro-proliferative responses independent of Ca2+ flux. Signifi-
cantly, reduction in 1,25(OH)D3 production or function because
of perturbations in biosynthetic or signaling genes decreased
HSPCs in zebrafish embryos. In contrast, 1,25(OH)D3 supple-
mentation expanded HSPCs in vivo and in vitro. Gene expres-
sion and epistasis studies indicated that 1,25(OH)D3 regulates
cxcl8 (IL-8) signaling to control HSPC numbers. Finally, ex vivo
treatment with 1,25(OH)D3 elicited significant elevations in sur-
vival, proliferation, and multi-lineage colony forming activity of
CD34+ human umbilical cord blood HSCs. Together, these
data highlight the conservation of 1,25(OH)D3 function in devel-
opmental HSC regulation and indicate the potential utility of
1,25(OH)D3 supplementation for HSPC expansion in clinical
transplantation therapies.
RESULTS
VDR Signaling Is Essential for Hematopoietic Stem and
Progenitor Cell Production
Despite case studies of hematological problems in children with
severe 1,25(OH)D3 deficiency, the effects on embryonic hema-
topoiesis remain uncharacterized. Vitamin D was identified as
a modulator of HSPC expression in a prior compound screen
(North et al., 2007). We recently showed that accumulation of
the inactive vitamin D precursor, cholecalciferol, negativelyaffected hemogenic endothelial formation, independent of VDR
activation, by directly antagonizing Hedgehog signaling (Cortes
et al., 2015). To investigate whether active 1,25(OH)D3-associ-
ated VDR signaling impacted definitive hematopoiesis, we
examined the effect of VDR loss on HSPC development. The ze-
brafish genome encodes two VDRs, vdra and vdrb, with vdra
alone acting as the canonical VDR in vivo (Lin et al., 2012). Frac-
tions from Tg(flk1:dsRed;cmyb:GFP) embryos (1,000 embryos/
sample 3 3 replicate sorts) isolated by fluorescence-activated
cell sorting (FACS) showed vdra expression in endothelial niche
cells (Flk1:dsRed+/cMyb:GFP) and HSPCs (Flk1:dsRed+/
cMyb:GFP+) (Figure S1A). Morpholino (MO) knockdown of vdra
strongly reduced runx1 expression in the aorta-gonad-meso-
nephros (AGM) region 36 hr post fertilization (hpf) by whole-
mount in situ hybridization (WISH) (Figure 1A) without overt
defects in the vascular niche, as marked by flk1 (Figure 1B)
and ephrinb2 (Figure S1B). This result was confirmed and quan-
tified by qPCR analysis (runx1, p < 0.01; flk1, p = not significant
[N.S.]; ephrinb2a, p = N.S.) (Figure 1C). In contrast, vdrb knock-
down had no effect on runx1 (Figure S1C). The specificity of the
vdraMOwas confirmed by splice product detection (Figure S1E)
and rescued by addition of vdra, but not vdrb, mRNA (Fig-
ure S1F). Importantly, generation of a vdra mutant embryo
by CRISPR-Cas9 genome editing (Figures S1G and S1H) re-
sulted in the same phenotypic effects on both runx1 (decreased)
and flk1 (unchanged) by WISH and qPCR (runx1, p < 0.01; flk1,
p = N.S.; ephrinb2, p = N.S.) (Figures 1D–1F). Whole-embryo
FACS quantification performed with the Tg(lmo2:GFP;gata1:
dsRed) line to mark functional erythro-myeloid progenitors
(EMPs) (Bertrand et al., 2007) and Tg(flk1:dsRed;cmyb:GFP) to
mark HSPCs (Bertrand et al., 2010) indicated a 20% (p < 0.05)
decrease at 30 hpf (Figure S1D) and 38% (p < 0.05) reduction
by 48 hpf (Figure 1G), respectively, with vdra knockdown.
Further, vdramorphants had sustained reductions in CD41:GFP+
HSCs colonizing the caudal hematopoietic tissue (CHT) at 72 hpf
in the Tg(-6.0itga2b(CD41):eGFP) line, as determined by fluores-
cence microscopy (Figure S1I) and FACS (Figure S1J; p < 0.01).
To confirm that the levels of vitamin D3/VDR activity correlated
with embryonic HSPC output, the impact of reduced vitamin D
synthesis was also examined. MO knockdown of cyp27b1,
which controls the final hydroxylation step in 1,25(OH)D3 synthe-
sis, diminished runx1/cmyb expression (Figure 1H). FACS anal-
ysis of cyp27b1 morphants confirmed a significant decrease
(p < 0.01) in HSPCs (Figure 1I), consistent with a role for
1,25(OH)D3/VDR activity in embryonic HSPC production.
Vitamin DSupplementation Stimulates Embryonic HSPC
Production
Because vitamin D synthesis and signaling appeared to be
necessary for the establishment of normal embryonic HSPC
numbers, we next examined whether supplementation was
sufficient to stimulate production. We previously determined
that cyp27b1 is expressed by 12 hpf (Cortes et al., 2015). Expo-
sure to exogenous 25(OH)D3 (10 mM), the circulating form of
vitamin D, enhanced runx1/cmyb expression (Figure 2A), which
was confirmed and quantified as a 2-fold increase in Flk1+/
cMyb+ HSPCs by FACS (p < 0.01; Figure 2B). Consistent with
biosynthetic processing by Cyp27b1 and VDR activation,Cell Reports 17, 458–468, October 4, 2016 459
Figure 1. VDR Is Necessary for Zebrafish Definitive Hematopoiesis
(A) Representative runx1WISH images and qualitative phenotype distribution (high/medium/low, nR 30 embryos/condition) of vdraMO-injected embryos and
sibling controls at 36 hpf. Error bars, mean ± SD.
(B) WISH example and phenotype distribution for flk1 in vdra morphants (nR 20 embryos/condition).
(C) qPCR analysis quantifying the impact on HSPCs (runx1, **p < 0.01) and hemogenic endothelium (flk1, ephrinb2a, p = N.S.) in control and vdramorphants (30
embryos/sample 3 3 replicates).
(D–F) Representative WISH (D), phenotype distributions (E), and qPCR quantification (F) of vdra mutant embryos (runx1, **p < 0.01; flk1, ephrinb2a, p = N.S.)
phenocopied the impact on HSPCs but not on vessels.
(G) FACS analysis of vdramorphants indicated significant reductions in Flk1:dsRed+/cMyb:GFP+ HSPCs (*p < 0.05) at 48 hpf (5 embryos/sample3 4 replicates/
condition). Error bars, mean ± SD.
(H) WISH samples and phenotype distribution of runx1/cmyb expression in cyp27b1 MO-injected embryos at 36 hpf (nR 30 embryos/condition).
(I) FACS analysis showed a significant decrease in HSPCs (**p < 0.01) with cyp27b1 MO injection (n value and error bars as in C).
Scale bars, 100 mm. See also Figure S1.25(OH)D3-treated embryos had elevated expression of the
VDR target cyp24a1 by qPCR at 36 hpf (p < 0.05), similar to
1,25(OH)D3 (p < 0.001; Figure 2C). VDR activation was
confirmed using a Tg(VDRE:mCherry) reporter line that showed
enhanced mCherry expression in the AGM with both 25(OH)D3
and 1,25(OH)D3 exposure (Figure S2A). Likewise, FACS indi-
cated a significant increase in Flk1:GPF+/VDRE:mCherry+ cells
with 1,25(OH)D3 (p < 0.0001; Figure S2B). To further examine
correlations between active vitamin D3 levels and HSPC produc-
tion, dosage analysis was performed. A dose-responsive induc-460 Cell Reports 17, 458–468, October 4, 2016tion in the distribution of embryos with high runx1/cmyb expres-
sion was seen with 0.1–10 mM 1,25(OH)D3 exposure (Figure 2D).
FACS quantification further revealed that exposure to 10 mM
1,25(OH)D3 caused a 25% (p < 0.01) increase in the number of
EMPs at 30 hpf (Figure S2C) and a 20% (p < 0.01) increase in
AGM-derived HSPCs at 48 hpf (Figure 2E). Together with
enhanced HSPC production, a 2-fold increase in proliferation
in the AGM was observed with 1,25(OH)D3 treatment (p <
0.001) compared with controls (Figure S2D) using the fluores-
cence ubiquitination cell cycle indicator (FUCCI) reporter
Figure 2. 1,25(OH)D3 Regulates HSPC Numbers via Vitamin D Receptor Signaling
(A) Representative runx1/cmyb WISH images and qualitative phenotype distribution following 25(OH)D3 exposure from 12–36 hpf (nR 40 embryos/condition).
(B) FACS analysis of 25(OH)D3-treated (10 mM) embryos showed a significant increase in HSPCs (**p < 0.01) (5 embryos/sample3 4 replicates/condition). Error
bars, mean ± SD.
(C) qPCR analysis indicated a significant induction in the VDR transcriptional target cyp24a1 at 36 hpf after exposure to 25(OH)D3 (*p < 0.05) or 1,25(OH)D3
(***p < 0.001) (12–36 hpf) (30 pooled embryos/condition 3 3 replicates).
(D) Phenotype distribution of runx1/cmyb expression in embryos exposed to increasing concentrations of 1,25(OH)D3 from 12–36 hpf (n R 30 embryos/
condition).
(E) FACS analysis of 1,25(OH)D3-treated (10 mM) embryos showed a 20% increase in HSPCs at 48 hpf (**p < 0.01) compared with controls (n value and error bars
as in B).
(F) runx1/cmyb WISH and phenotype distribution after exposure to the non-calcemic vitamin D3 analog calcipotriol (nR 30 embryos/condition).
(G) FACS analysis of calcipotriol-treated embryos showed a significantly more HSPCs (*p < 0.05) at 36 hpf (n value and error bars as in B).
Scale bars, 100 mm. See also Figure S2.Tg(EF1:mAG-zGEM(1/100) line (Sugiyama et al., 2009) crossed
to Tg(flk1:dsred). In contrast, vdra knockdown caused a signifi-
cant decrease in proliferation (p < 0.05; Figure S2E). Finally, to
determine whether the effect of 1,25(OH)D3 was due to VDR-
mediated transcriptional regulation or alterations in Ca2+ flux,
embryos were treated with the vitamin D3 analog calcipotriol,documented to be 100-fold less calcemic than 1,25(OH)D3
(Binderup andBramm, 1988). Calcipotriol (10 mM) shifted the dis-
tribution of embryos with increased runx1/cmyb expression in a
manner phenotypically comparable with 1,25(OH)D3 (Figure 2F)
and caused a 29% elevation in Flk1+cMyb+ HSPCs (p < 0.05) by
FACS (Figure 2G). Furthermore, the impact of both 1,25(OH)D3Cell Reports 17, 458–468, October 4, 2016 461
Figure 3. 1,25(OH)D3 Stimulates Cell-Auton-
omous HSPC Expansion
(A) Representative FACS plots of DMSO- and cal-
cipotriol-treated (20 mM) adult zebrafish at 10 dpi
showing that calcipotriol enhanced the percentage
of FSC/SSC-gated HSPCs (n = 9 adults/condition).
(B) Calcipotriol-treated adults had a 34% (**p <
0.01) increase in HSPCs compared with controls at
10 dpi (error bars, mean ± SD) by FACS.
(C) Adult KM HSPCs cultured with 1,25(OH)D3 for
6 days on ZEST cells demonstrated increased
proliferation (**p < 0.01) compared with controls
(n = 3). Error bars, mean ± SD.
(D) Methylcellulose CFU assay of adult whole
KM (WKM) cells cultured with of 1,25(OH)D3
(1 3 107 M) displayed a 40% (*p < 0.05) increase
in total colonies compared with DMSO controls
(n = 3). Error bars, mean ± SD.
(E) CFU assay of CD41:GFP+ KM cultured in the
presence of 1 3 106 and 1 3 107 M 1,25(OH)D3
and sorted by FACS showed a 55% (**p < 0.01)
and 57% (**p < 0.01) elevation, respectively, in
colony numbers versus controls (n = 3). Error bars,
mean ± SD.
See also Figure S3.and calcipotriol was sustained in the CHT at 72 hpf, as deter-
mined by microscopy and FACS for CD41:GFP+ (control [con]
versus 1,25(OH)D3, p < 0.05; con versus calcipotriol, p < 0.01)
(Figures S2F and S2G). Together, these data indicate that
vitamin D3-mediated regulation of embryonic HSPC production
occurs via stimulation of VDR activity and cell proliferation inde-
pendent of impact on Ca2+ regulation.
1,25(OH)D3 Increases Adult HSPC Production and
Function In Vivo and In Vitro
Unlike the mammalian BM niche, which is directly affected by
vitamin D/VDR-mediated Ca2+ flux, adult zebrafish kidney
marrow (KM) allows for analysis of 1,25(OH)D3 function indepen-
dent of osteoregulation. To determine whether embryonic
modulation of vitamin D production or signaling had long-term
consequences, KM was dissected and subjected to FACS for-
ward scatter (FSC)/side scatter (SSC) profiling (Stachura and
Traver, 2016). KM from zebrafish exposed to exogenous
1,25(OH)D3 transiently as embryos (1236 hpf) did not differ
from control siblings (Figure S3A). In contrast, both cyp2r1 and
vdra mutants showed significant reductions in cells within the
‘‘lymphoid’’ gate (p < 0.05), which includes both lymphoid pro-
genitors and HSCs (Stachura and Traver, 2016), implying that
vitamin D sufficiency is necessary to establish normal HSPC
numbers (Figures S3B and S3C).
To investigate whether 1,25(OH)D3 supplementation could
stimulate HSPC production in the adult, KM irradiation recovery
experiments were performed (North et al., 2007). Consistent with
adverse effects observed in the clinic (Leyssens et al., 2014),
systemic treatment with 1,25(OH)D3 (10 mM) following irradiation
was toxic, likely because of hypercalcemia, precluding further
analysis. In contrast, exposure to calcipotriol for 24 hr at
2 days post sub-lethal irradiation (dpi) caused a significant462 Cell Reports 17, 458–468, October 4, 201634% enhancement (p < 0.01) in the recovery of HSPCs at
10 dpi compared with DMSO-treated controls (Figures 3A and
3B). To further characterize the impact of vitamin D3 supplemen-
tation, manually isolated whole KMwas cultured on either zebra-
fish embryonic stromal trunk (ZEST) cells or zebrafish kidney
stromal (ZKS) cells (Campbell et al., 2015). After 6 days in culture,
a significant increase in total hematopoietic cells was observed
with 1,25(OH)D3 exposure (ZEST, p < 0.01; ZKS, p < 0.01) (Fig-
ure 3C; Figure S3D), indicative of pro-proliferative stimulation. To
determine whether 1,25(OH)D3 had a direct impact on HSPC
function, methylcellulose hematopoietic colony-forming assays
were performed (Stachura et al., 2011). Dissociated KM
plated in the presence of 1,25(OH)D3 (1 3 106 M) showed a
40% increase (p < 0.05) in total colony forming units, culture
(CFU-C) compared with DMSO controls (Figure 3D) on day 10
after plating. Significantly, FACS-sorted CD41:GFP+ KM HSPCs
cultured with 1,25(OH)D3 displayed a similar expansion
(13 106 M, 55% increase, p < 0.01; 13 107 M, 57% increase,
p < 0.01) (Figure 3E), indicating that adult HSPCs can respond
cell-autonomously to vitamin D3 stimulation to boost HSPC pro-
duction and function, independent of osteoregulation.
1,25(OH)D3 Enhances In Vitro Function of CD34+ Human
Umbilical Cord Blood
Given the strong pro-HSPC expansion effect observed in vivo
and in vitro in zebrafish, we next investigated whether the regu-
latory impact of 1,25(OH)D3 was conserved in mammalian
HSPCs. VDR is expressed on highly enriched murine HSCs (Rid-
dell et al., 2014) as well as human CD34+ hematopoietic progen-
itors (Grande et al., 2002). Expression of the human VDR was
confirmed in commercially available de-identified whole (unfrac-
tionated) and CD34+ human umbilical cord blood (hUCB) by
qPCR (Figure S4A). Ex vivo treatment with 1,25(OH)D3 for 4 hr
Figure 4. Ex Vivo 1,25(OH)D3 Exposure In-
creases hUCB CD34+ HSPCs
(A) qPCR analysis for the known VDR target
CYP24A1 showed increased expression (****p <
0.0001) in individual whole and CD34+ (*p < 0.05)
hUCB units split and treated with 1,25(OH)D3
versus DMSO (vehicle) control (n = 3 hUCB units).
Error bars, mean ± SD.
(B) Whole (umbilical) cord blood (WCB) cells
treated with 1,25(OH)D3 (4 hr) had significantly
increased EdU labeling (*p < 0.05) of CD34+CD45lo
HSCs compared with matched controls (n = 2).
Error bars, mean ± SD.
(C) Annexin-V/7-AAD FACS analysis of CD34+
hUCB showed a significant decrease (*p < 0.05,
n = 3) in apoptosis with 1,25(OH)D3 treatment.
(D) In vitro methylcellulose assays of CD34+ hUCB
treated ex vivo with 1,25(OH)D3 (1 3 106 M) for
4 hr revealed a 38% (*p < 0.05) increase in total
CFU numbers compared with DMSO controls on
day 7 after plating (five independent single donor
hUCB samples split for treatment and analysis).
Error bars, mean ± SD.
(E) 1,25(OH)D3 treatment enhanced all colony
types (CFU-E, CFU-GM, and CFU-GEMM) on day
10 versus matched controls (ANOVA, *p < 0.05),
with a significant increase in GEMMs (Fisher’s least
significant difference [LSD] test, *p < 0.05). n = 5;
error bars, ± SEM.
(F) Top canonical pathways enriched by 1,25(OH)
D3 exposure based on IPA of significantly ex-
pressed genes. False discovery rate (FDR) < 0.05
(n = 2 single donor CD34+ hUCBs); IL-8 (CXCL8).
Signaling is highlighted in bold type.
(G) qPCR analysis of CD34+ hUCBcells exposed to
1,25(OH)D3 (4 hr) showed a significant increase in
CXCL8 expression (*p < 0.05) (n = 3). Error bars,
mean ± SD.
(H) FACS quantification for CXCL8 protein content
in CD34+ hUCBs showed a significant increase
with 1,25(OH)D3 treatment (**p < 0.01 n = 4; error
bars, mean ± SD).
See also Figure S4.led to significant upregulation of CYP24A1 in both whole
(p < 0.0001) and CD34+ (p < 0.05) hUCB cells (Figure 4A), indic-
ative of VDR activation. Consistent with pro-proliferative effects
in zebrafish, 5-ethyl-20-deoxyuridine (EdU) labeling (10 mM, 1 hr)
of whole hUCB cells exposed to 1,25(OH)D3 (1 mM, 4 hr)
indicated a 35% increase (p < 0.05) in DNA synthesis in the
CD34+/CD45lo HSPC population compared with controls (Fig-
ure 4B). 1,25(OH)D3-treated CD34+ hUCB samples also showed
significantly decreased cell death (p < 0.05), as determined by
FACS for the apoptosis marker Annexin V (Figure 4C). To assess
whether vitamin D3 would elicit a positive impact on in vitro
expansion and function of mammalian HSPCs, CFU-C assays
were performed. Ex vivo incubation of CD34+ hUCB HSCs
(n = 5 single donor hUCB units split for treatment and plated in
replicate) with 1,25(OH)D3 for 4 hr at 37C increased average
total colony numbers at 7 days after plating by 38% (p < 0.05)
compared with matched DMSO-treated controls (Figure 4D).
This effect was concentration-dependent, where 1 3 107 and
1 3 106 M elicited a 39% (p < 0.05) and 56% elevation(p < 0.01) in colonies, respectively, whereas a higher dose of
1,25(OH)D3 (1 3 105 M) was refractory to expansion (Fig-
ure S4B). Analysis of the differentiation potential on day 10 after
plating indicated that each progenitor fraction (colony forming
unit, erythroid [CFU-E], colony forming unit, granulocyte/mono-
cyte [CFU-GM], and colony forming unit, granulocyte/erythro-
cyte/monocyte/megakaryocyte [CFU-GEMM]) was increased
by short-term, low-dose 1,25(OH)D3 exposure (1 3 106 M,
p < 0.0.05) (Figure 4E). Further, the CFU-GEMM population in
particular was significantly enhanced (p < 0.05), consistent
with an impact on multipotent HSPCs.
Because VDR is a known transcriptional regulator, changes in
gene expression due to 1,25(OH)D3 exposure relevant to the
observed in vitro hematopoietic phenotypes were examined.
Response to short-term 1,25(OH)D3 (4-hr) exposure was vali-
dated by qPCR, where, in addition to enhanced expression of
CYP24A1 (Figure 4A), the established VDR target and cell cycle
regulator G0S2 (Singh et al., 2014), and the anti-apoptotic BCL2
(Vaux et al., 1988) were each elevated (Figure S4C). Further,Cell Reports 17, 458–468, October 4, 2016 463
although individual hUCB units showed differential responses to
vitamin D3 stimulation, both Ingenuity Pathway (IPA) and
MetaCore analyses revealed overlapping gene networks. In
particular, IPA analysis indicated ‘‘IL-8 signaling’’ as a signifi-
cantly regulated canonical pathway, whereas IL-8 (CXCL8) was
a relevant component of three of the top ten MetaCore networks
(Figure 4F; Figure S4D). The chemokine CXCL8 was shown pre-
viously to contain a functional VDRE in its promoter (Ryyna¨nen
and Carlberg, 2013) and exhibit an early transcriptional response
to 1,25(OH)D3 stimulation in HL60 cells (Savli et al., 2002). The
CXCL8 receptors CXCR1 and CXCR2 are expressed in hUCB,
including the CD34+ fraction (Figure S4E). In response to
1,25(OH)D3 stimulation, CD34+ hUCB HSCs showed a signifi-
cant induction in CXCL8 expression (p < 0.05) (Figure 4G).
FACS analysis following monensin treatment to inhibit cytokine
secretion confirmed a 40% increase (p < 0.01) in CXCL8 protein
content in CD34+ hUCB cells with 1,25(OH)D3 exposure (Fig-
ure 4H), indicating CXCL8 as a relevant VDR target in HSPCs.
1,25(OH)D3 Regulates CXCL8 Signaling to Modulate
HSPC Production
We recently showed inflammatory activity stimulates develop-
mental HSC production in zebrafish and mice (Li et al., 2014).
CXCL8 is a potent regulator of chemotaxis, proliferation, and
survival in the hemato-vascular system in response to inflamma-
tory stimuli (de Oliveira et al., 2013). To investigate whether
the effect of 1,25(OH)D3 on HSPCs was mediated by Cxcl8
signaling, modified epistasis studies were conducted in zebra-
fish. Embryos treated with 1,25(OH)D3 displayed elevated
cxcl8 expression, as assessed by WISH (Figure 5A) and quanti-
fied bywhole-embryo qRT-PCR (p < 0.05) (Figure 5B). Moreover,
qRT-PCR analysis of sorted cell fractions showed a 4-fold in-
crease in cxcl8 expression specifically in Flk1+cMyb+ HSPCs
(Figure S5A). Consistent with autocrine or paracrine inflamma-
tory stimulation of HSPCs, the Cxcl8 receptors cxcr1 and
cxcr2 are expressed in the vascular and/or hematopoietic
fractions of the embryo (Figure S5B). Further, injection of
cxcl8 mRNA elicited a dose-dependent expansion in HSPCs
(p < 0.05) reminiscent of 1,25(OH)D3 treatment (Figure 5C).
Use of a previously validated morpholino to cxcl8 (Stoll et al.,
2011) attenuated the shift in the fraction of embryos with
elevated runx/cmyb expression (Figure 5D) as well as the boost
in Flk1+cMyb+ HSPCs mediated by 1,25(OH)D3 (con versus
1,25(OH)D3, p < 0.05; con versus cxcl8 MO, N.S.; cxcl8 MO
versus cxcl8 MO + 1,25(OH)D3, N.S.; 1,25(OH)D3 versus
1,25(OH)D3 + cxcl8 MO, N.S.) (Figure 5E), resulting in no differ-
ence from controls. Likewise, co-treatment with the CXCR1/2 in-
hibitor SB225002 (White et al., 1998) reduced the overall
response of HSPCs to 1,25(OH)D3 stimulation, as determined
by WISH (Figure S5C) and FACS (Figure S5D) (con versus
1,25(OH)D3, p < 0.01; 1,25(OH)D3 versus SB25002, p < 0.01;
con versus 1,25(OH)D3 + SB25002, N.S.; 1,25(OH)D3 versus
1,25(OH)D3 + SB25002, N.S.). Cxcl8-Cxcr1/2 signaling elicits
functional responses via activation of a number of intracellular
mediators. In particular, AKT signaling downstream of Cxcr1/2
stimulation influences apoptosis and proliferation (Waugh and
Wilson, 2008). Exposure to 1,25(OH)D3 (12–36 hpf) increased
total phosphorylated AKT (pAKT) levels by western analysis (Fig-464 Cell Reports 17, 458–468, October 4, 2016ure 5F). Significantly, this effect was not observed in cxcl8 mu-
tants. Likewise, in vitro exposure to the CXCL1/2 inhibitor
SB225002 blocked KM HSPC expansion in the context of
1,25(OH)D3 stimulation in ZEST co-culture assays (Figure 5G)
(con versus 1,25(OH)D3, p < 0.0001; con versus SB225002,
p < 0.05; con versus 1,25(OH)D3 + SB25002, N.S.;1,25(OH)D3
versus 1,25(OH)D3 + SB25502, p < 0.0001). Finally, co-treat-
ment with SB225002 antagonized functional enhancements in
KMCFU numbers mediated by 1,25(OH)D3 or calcipotriol during
in vitro methylcellulose culture (Figure 5H) (con versus 1,25(OH)
D3, p < 0.01; con versus calcipotriol, p < 0.01; con versus
SB225002, p < 0.05; con versus 1,25(OH)D3 + SB25502, N.S.;
con versus calcipotriol + SB25502, N.S.). Together, our studies
demonstrate that CXCL8-CXCR1/2 signaling functions down-
stream of 1,25(OH)D3-mediated VDR stimulation to directly
regulate HSPC production and expansion.
DISCUSSION
Vitamin D has an established role in bone maintenance; severe
developmental 1,25(OH)D3 deficiency results in abnormal bone
mineralization (rickets) that can be treated clinically with vitamin
D2 or D3 supplementation. Interestingly, VDR is expressed in
many cell types, implying that it may have additional roles in
other organs, including the hematopoietic system (Christakos
et al., 2013; Plum and DeLuca, 2010). However, important differ-
ences in vitamin D biology and its regulatory impact on mamma-
lian cells have been observed. In particular, transcriptional target
genes relating to immune regulation are differentially regulated
by vitamin D inmice comparedwith humans (Dimitrov andWhite,
2015). Further, vitamin D synthesis in mice is not exclusively
dependent on Cyp2r1 as in humans, likely explaining the unex-
pected lack of phenotypes in knockout models (Zhu et al.,
2013). In this study, we took advantage of the conservation of
the vitamin D synthesis and signaling pathway in teleosts (Lin
et al., 2012) and the amenability of zebrafish to chemical and ge-
netic manipulation to characterize the direct impact of 1,25(OH)
D3 availability on HSPC development. Here we found that active
vitamin D3 is both necessary and sufficient to modify embryonic
HSPC production. Further, we revealed that this effect is due to
VDR-mediated transcriptional activation of the inflammatory
chemokine CXCL8, stimulating cell-autonomous regulation of
HSPC expansion and viability via CXCR1/2 activity.
Although CXCL8 is a potent chemo-attractant for neutrophils
and functions as part of the inflammatory response (Deng
et al., 2013), recent studies in zebrafish have indicated that it
can modulate hematopoietic stem cell formation (Jing et al.,
2015). Our findings support a model in which vitamin D/VDR-
mediated induction of CXCL8 acts in an autocrine/paracrine
manner to promote HSPC survival and proliferation, similar to
its function in endometrial stroma cells (Arici et al., 1998). Prior
reports indicate that, in contrast to BM and mobilized peripheral
blood populations, CXCR1 and CXCR2 expression is highly en-
riched in hUCB HSCs (Rosu-Myles et al., 2000), perhaps indi-
cating a fundamental difference in responsiveness to CXCL8
signaling between adult and gestational HSPC sources. Interest-
ingly, although we observe an increase in CXCL8 expression in
both zebrafish and hUCB in response to 1,25(OH)D3, the impact
Figure 5. 1,25(OH)D3 Mediates HSPC Expansion through CXCL8 Signaling
(A) WISH for cxcl8 showing elevated expression with 1,25(OH)D3 treatment at 36 hpf (nR 30 embryos/condition).
(B) Whole-embryo qPCR confirmed increased cxcl8 expression at 36 hpf after 1,25(OH)D3 exposure (*p < 0.05) (40 pooled embryos/condition 3 3 replicates).
Error bars, mean ± SD.
(C) FACS analysis of embryos injected with cxcl8 mRNA (100 ng/embryo) showed increased Flk1:dsRed+/cMyb:GFP+ HSPCs at 36 hpf (*p < 0.05) (5 embryos/
sample 3 4 replicates/condition). Error bars, mean ± SD.
(D) WISH analysis and phenotype distribution indicated that the effect of 1,25(OH)D3 on runx1/cmyb expression was diminished in cxcl8 morphants (n R 35
embryos/condition).
(E) FACS analysis of MO-injected embryos treated with 1,25(OH)D3 (con versus 1,25(OH)D3, *p < 0.05; con versus cxcl8MO, N.S.; cxcl8MO versus cxcl8 MO +
1,25(OH)D3, N.S.; 1,25(OH)D3 versus 1,25(OH)D3 + cxcl8MO,N.S.)(5 embryos/sample3 4 replicates/condition; error bars, mean ±SD) showed that loss of cxcl8
blocked vitamin D-mediated HSPC expansion.
(F) Western blot analysis for pAKT, with AKT as loading control, following 1,25(OH)D3 stimulation (12–36 hpf) in cxcl8 mutants versus WT siblings (60 embryos/
condition).
(G) WKM stromal cell assay documenting changes in proliferation by 1,25(OH)D3 with and without co-incubation with SB25002 (con versus 1,25(OH)D3,
****p < 0.0001; con versus SB225002, p < 0.05; con versus 1,25(OH)D3 + SB25002, N.S.; 1,25(OH)D3 versus 1,25(OH)D3 + SB25502, ****p < 0.0001) (n = 4; error
bars, mean ± SD).
(H) WKMmethylcellulose CFU assay showing fold increase with and without co-treatment of 1,25(OH)D3 with SB25002 (con versus 1,25(OH)D3, **p < 0.01; con
versus calcipotriol, **p < 0.01; con versus SB225002, *p < 0.05; con versus 1,25(OH)D3 +SB25502, N.S.; con versus calcipotriol + SB25502, N.S.). n = 4 (SB25503
is n = 6); error bars, mean ± SD.
Scale bars, 100 mm. See also Figure S5.of loss of Cxcl8-Cxcr1/2 signalingwasmost striking in the setting
of vitamin D supplementation. These data imply that, although
CXCL8 is a functional target of VDR stimulation, additional
studies will be needed to identify whether other factors cancontribute to overlapping or complementary aspects of VDR-
mediated HSPC regulation in this or other contexts. Our findings
also expand on the recent appreciation of the important role(s) of
pro-inflammatory regulation in HSC induction and expansionCell Reports 17, 458–468, October 4, 2016 465
during embryogenesis (Espı´n-Palazo´n et al., 2014; Li et al.,
2014), which may serve as valid targets for therapeutic exploita-
tion as proposed here.
Vitamin D has been investigated previously as a treatment for
hematologic malignancy, albeit in a different context than pre-
sented here. Similar to use of retinoic acid for terminal differenti-
ation of blasts in acute promyelocytic leukemia (APL), several
in vitro studies showed that vitamin D treatment caused differen-
tiation of leukemic precursors to the monocytic lineage (Hughes
et al., 2010). These findings led to in vivo studies and phase 1
clinical trials for the use of vitamin D as a differentiation agent
for acute myeloid leukemia (AML), which ultimately proved to
be unsuccessful because of hypercalcemia and heterogeneity
of the AML subtypes tested (Marchwicka et al., 2014). Interest-
ingly, although treatment of the HL-60 leukemia cell line with
1,25(OH)D3 required 18–20 hr of exposure for differentiation to
begin (Mangelsdorf et al., 1984), an initial burst in proliferation
was seen during early phases (Brown et al., 1999), similar to
the effect on HSPCs observed here. Our data indicate that
1,25(OH)D3 stimulates proliferative HSPC expansion. Consis-
tent with this role, loss of 1,25(OH)D3 production or VDR function
reduced HSPCs in vivo. Further, in vitro assays of both CD41+
zebrafish HSCs and CD34+ hUCB HSPCs revealed cell autono-
mous responses to short-term, low-dose 1,25(OH)D3 supple-
mentation, independent of the niche, increasing multi-lineage
CFU numbers via VDR-mediated alterations in proliferation and
survival. These data are particularly relevant in the context of
clinical observations of vitamin D-deficient pediatric and adult
HSC transplant recipients who demonstrate a poor outcome,
including graft versus host disease, delayed time to neutrophil
engraftment, and overall survival (von Bahr et al., 2015; Wallace
et al., 2015). Together, our data indicate that, beyond the pub-
lished effects on lineage differentiation and immune-regulation,
vitamin D has an important role in the foundation of the hemato-
poietic tree, regulating definitive HSPC numbers in the embryo.
Beyond the evolutionary conservation of 1,25(OH)D3/VDR-
mediated regulation of HSPC numbers, cord-to-cord variability
in our experimental and expression analyses highlight the poten-
tial clinical relevance of vitamin D status on hUCB function,
particularly in regard to current ex vivo expansion and transplan-
tation protocols. Vitamin D deficiency is a significant problem
among pregnant women, ranging from 40%–50% in the northern
United States (Bodnar et al., 2007). Extrapolating from these
numbers, it is safe to assume that many hUCB samples are
collected from vitamin D-deficient donors. In our hands, we
observed variability in the magnitude of HSPC response among
the treated hUCB samples, which we postulate may be attrib-
uted to the vitamin D status of the donor. Because 50% of
transplanted HSC units cause treatment-related complications,
including graft failure (10%) and/or delayed time to transplant re-
covery (Singh et al., 2014), there are clearly still significant gaps
in our understanding of the full array of factors contributing to
donor HSPC function. In future investigations, it will be of scien-
tific and clinical interest to obtain the vitamin D status of the
donor (or sample) to determine whether the magnitude of
in vitro expansion, transplant efficacy, and/or response to
1,25(OH)D3 stimulation depends on the original status of the
unit. In sum, we have elucidated a fundamental role of vitamin466 Cell Reports 17, 458–468, October 4, 2016D availability in regulating embryonic HSPC production, high-
lighting the functional potential of nutritional vitamin D supple-
mentation for clinical hUCB expansion.
EXPERIMENTAL PROCEDURES
Zebrafish Husbandry
Zebrafish lines were maintained and utilized in accordance with the Beth
Israel Deaconess Medical Center (BIDMC) Institutional Animal Care and Use
Committee (IACUC). The zebrafish lines used included AB, T€ubingen (TU),
and mutants and transgenics described in the Supplemental Experimental
Procedures.
Chemical Treatments
Zebrafish embryos were exposed to chemical modulators in E3 fish medium
from 12–36 hpf in multi-well plates unless noted otherwise. The following com-
pounds (dose, supplier) were used: 1,25(OH)2D3 (1–-10 mM, Cayman Chemi-
cal), Calcipotriol (1–10 mM, Cayman Chemical), SB225002 (1 mM, Cayman
Chemical), and 25(OH)D3 (10 mM, Tocris). Treated embryos were analyzed
by WISH based on established protocols and utilizing published probes
(Cortes et al., 2015). Phenotypic variation (n R 20 embryos/condition, nR 3
replicate clutches) was qualitatively analyzed as relatively high (up), medium
(normal), or low (down) expression compared with age/stage-matched sibling
controls and graphically depicted as the percentage falling into each of the
three phenotypic expression bins. Normal expression reflected the most
representative phenotype in the bell curve distribution of each cohort of control
embryos per experiment. Images were acquired using a Zeiss Axio Imager
A1/Axio Cam MRC using Axio vision LE software.
Morpholino and mRNA Injection
Translation blocking or splice-site MOs (Gene Tools) against ZF vdra, vdrb,
cyp27b1, and cxcl8 (Supplemental Experimental Procedures) were injected
at the one-cell stage.
Embryo Dissociation and FACS Analysis
Fluorescent embryos (5 embryos/sample 3 4 replicates/condition) were
dissociated, resuspended in 3 PBS, and analyzed on a BD FACS Canto II in
the presence of SYTOX Red dead cell stain (5 nM, Life Technologies) as
described previously (Cortes et al., 2015). Data were analyzed using FlowJo
X software (Tree Star). Double-negative, Flk1+/cMyb, and Flk1+/cMyb+ cells
were sorted (1,000 embryos/sample 3 3 replicate sorts) on a BD SORP FACS
Aria (BIDMC Flow Cytometry Core).
Expression Analysis
Total RNA was purified from zebrafish embryos (40 embryos/condition), hu-
man CD34+ cells (500,000 cells/condition), or mononuclear UCB (one million
cells/condition) using the RNAqueous Micro kit (Life Technologies) followed
by Turbo DNase-I treatment (Life Technologies). For sorted populations,
cDNA amplification was performed using the NuGEN Ovation Pico WTA2 sys-
tem. For embryos, 1 mg of total RNA was used to generate cDNA using Super-
script III First Strand Synthesis Supermix (Life Technologies). Superscript VILO
mastermix was used for human RNA samples (<1 mg of RNA). Quantitative
real-time PCR was performed using SYBR Green PCR Master Mix (Life Tech-
nologies) on a Bio-Rad CFX384 Touch. Samples were run in triplicate with
more than three biological replicates using published primers (Supplemental
Experimental Procedures). Data analysis was performed using Real PCR
Miner (http://ewindup.info/miner/).
Adult Kidney Marrow Analysis
KM from adult cyp2r1 and vdra mutants and their wild-type (WT) siblings was
dissected and analyzed by SSC versus FCS FACS profiling after red blood cell
lysis as described previously (Stachura and Traver, 2016). Irradiation recovery
was performed as described previously (North et al., 2007). Adult male zebra-
fish were exposed to 20 Gy of g-irradiation and treated at 2 days post irradia-
tion (dpi) with calcipotriol (20 mM) in the fish water. KM was dissected and
analyzed at 10 dpi by FACS profiling on a Beckman Coulter Gallios flow
cytometer (BIDMC Flow Cytometry Core). Percent HSPC recovery was
analyzed by FlowJo X.
In Vitro Functional Analysis
Hematopoietic in vitro function assays were performed as described previ-
ously for zebrafish (Campbell et al., 2015; Stachura et al., 2011) and human
cells (Goessling et al., 2011) and are detailed in the Supplemental Experimental
Procedures.
Statistical Analysis
Statistical analyses were performed using Prism 6 (GraphPad). Two-tailed
Student’s t tests were used for pairwise comparisons and ANOVA for
group analyses, with Holm-Sidak post hoc tests. Data are represented as
mean ± SD. *p < 0.05; ** p < 0.01; ***p < 0.001; N.D., not detected.
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